Blute ML - Search Results

1

The preoperative erythrocyte sedimentation rate is an independent prognostic factor in renal cell carcinoma.

Sengupta S, Lohse CM, Cheville JC, Leibovich BC, Thompson RH, Webster WS, Frank I, Zincke H, Blute ML, Kwon ED. Sengupta S, et al. Among authors: blute ml. Cancer. 2006 Jan 15;106(2):304-12. doi: 10.1002/cncr.21617. Cancer. 2006. PMID: 16353202 Free article.

2

Radical prostatectomy for stage A adenocarcinoma of the prostate: staging errors and their implications for treatment recommendations and disease outcome.

Zincke H, Blute ML, Fallen MJ, Farrow GM. Zincke H, et al. Among authors: blute ml. J Urol. 1991 Oct;146(4):1053-8. doi: 10.1016/s0022-5347(17)37999-5. J Urol. 1991. PMID: 1895421

3

Stage B prostate adenocarcinoma. Flow cytometric nuclear DNA ploidy analysis.

Montgomery BT, Nativ O, Blute ML, Farrow GM, Myers RP, Zincke H, Therneau TM, Lieber MM. Montgomery BT, et al. Among authors: blute ml. Arch Surg. 1990 Mar;125(3):327-31. doi: 10.1001/archsurg.1990.01410150049010. Arch Surg. 1990. PMID: 2306181

4

Impact of endourology on diagnosis and management of upper urinary tract urothelial cancer.

Blute ML, Segura JW, Patterson DE, Benson RC Jr, Zincke H. Blute ML, et al. J Urol. 1989 Jun;141(6):1298-301. doi: 10.1016/s0022-5347(17)41286-9. J Urol. 1989. PMID: 2724425

5

Pattern of failure after radical retropubic prostatectomy for clinically and pathologically localized adenocarcinoma of the prostate: influence of tumor deoxyribonucleic acid ploidy.

Blute ML, Nativ O, Zincke H, Farrow GM, Therneau T, Lieber MM. Blute ML, et al. J Urol. 1989 Nov;142(5):1262-5. doi: 10.1016/s0022-5347(17)39051-1. J Urol. 1989. PMID: 2810503

6

Transitional cell carcinoma of the renal pelvis: nuclear deoxyribonucleic acid ploidy studied by flow cytometry.

Blute ML, Tsushima K, Farrow GM, Therneau TM, Lieber MM. Blute ML, et al. J Urol. 1988 Nov;140(5):944-9. doi: 10.1016/s0022-5347(17)41894-5. J Urol. 1988. PMID: 3172363

7

Long-term followup of young patients with stage A adenocarcinoma of the prostate.

Blute ML, Zincke H, Farrow GM. Blute ML, et al. J Urol. 1986 Oct;136(4):840-3. doi: 10.1016/s0022-5347(17)45098-1. J Urol. 1986. PMID: 3761443

8

Long-term (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer.

Zincke H, Oesterling JE, Blute ML, Bergstralh EJ, Myers RP, Barrett DM. Zincke H, et al. Among authors: blute ml. J Urol. 1994 Nov;152(5 Pt 2):1850-7. doi: 10.1016/s0022-5347(17)32399-6. J Urol. 1994. PMID: 7523733

9

Critical evaluation of salvage surgery for radio-recurrent/resistant prostate cancer.

Lerner SE, Blute ML, Zincke H. Lerner SE, et al. Among authors: blute ml. J Urol. 1995 Sep;154(3):1103-9. J Urol. 1995. PMID: 7543608 Clinical Trial.

10

Primary chemotherapy for clinical stage II nonseminomatous germ cell testicular tumors: selection criteria and long-term results.

Lerner SE, Mann BS, Blute ML, Richardson RL, Zincke H. Lerner SE, et al. Among authors: blute ml. Mayo Clin Proc. 1995 Sep;70(9):821-8. doi: 10.1016/S0025-6196(11)63938-4. Mayo Clin Proc. 1995. PMID: 7543967

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

424 results

Search Page

Filters